{
    "type": "malware",
    "spec_version": "2.1",
    "id": "malware--79c652e5-6478-4e2a-abbd-12b8c9e993a3",
    "created": "2024-08-13T14:48:38.963628Z",
    "modified": "2024-08-13T14:48:38.963632Z",
    "name": "SoreFang",
    "description": "SoreFang is first stage downloader used by APT29 for exfiltration and to load other malware.[1][2]",
    "is_family": false,
    "labels": [
        "malware"
    ],
    "object_marking_refs": [
        "marking-definition--613f2e26-407d-48c7-9eca-b8e91df99dc9"
    ],
    "x_mitre_platforms": [
        "Windows"
    ],
    "x_mitre_deprecated": false,
    "x_mitre_domains": [
        "enterprise-attack"
    ],
    "x_mitre_version": "1.0",
    "x_mitre_aliases": [
        "SoreFang"
    ],
    "external_references": [
        {
            "external_id": "S0516",
            "source_name": "mitre-attack",
            "url": "https://attack.mitre.org/software/S0516"
        },
        {
            "source_name": "NCSC APT29 July 2020",
            "url": "https://www.ncsc.gov.uk/files/Advisory-APT29-targets-COVID-19-vaccine-development-V1-1.pdf",
            "description": "National Cyber Security Centre. (2020, July 16). Advisory: APT29 targets COVID-19 vaccine development. Retrieved September 29, 2020."
        },
        {
            "source_name": "CISA SoreFang July 2016",
            "url": "https://us-cert.cisa.gov/ncas/analysis-reports/ar20-198a",
            "description": "CISA. (2020, July 16). MAR-10296782-1.v1 \u2013 SOREFANG. Retrieved September 29, 2020."
        }
    ]
}